The Potential Utility of Ashwagandha for Improving Cognitive Dysfunction in Persons with Bipolar or Other Neurocognitive Disorders View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2017-09-12

AUTHORS

K. N. Roy Chengappa , Jessica M. Gannon , Luna Acharya , Abhishek Rai

ABSTRACT

Bipolar Disorder is a mood disorder that can be quite severe for subgroups of patients, and often such patients manifest deficits in attention, concentration, memory, and executive functions that persist even when they are relatively well. Cognitive concerns can impair daily life functioning and impact employment, education, and interpersonal relationships. Main line treatments for bipolar disorder typically do not address cognitive impairments, and some treatments may actually worsen cognitive deficits. Treatment development for cognitive impairments in bipolar disorder is truly in its infancy; extracts of Ashwagandha (Withania somnifera) may hold promise as a potential treatment option. The bioactive constituents of Ashwagandha, including withanolides, indosides, Withaferin A, and others, possess anti-inflammatory-immunomodulatory, anti-oxidant, cortisol lowering, anti-stress, pro-cholinergic, anti-glutamatergic and neuroprotective properties, the very processes that are thought to underlie cognitive impairments not only in in bipolar disorder but also in other psychiatric disorders like schizophrenia and major depression. This chapter reviews this in detail and highlights the preliminary randomized controlled study assessing an extract of Ashwagandha for improving cognition in bipolar disorder. The chapter also explores the potential role of Ashwagandha extracts in the treatment of other neurocognitive disorders, and it concludes by summarizing additional future research needed to realize the potential of this ancient medicinal plant for the treatment of human ailments. More... »

PAGES

345-371

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-319-59192-6_17

DOI

http://dx.doi.org/10.1007/978-3-319-59192-6_17

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1091686017


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/17", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Psychology and Cognitive Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1701", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Psychology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.21925.3d", 
          "name": [
            "Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Roy Chengappa", 
        "givenName": "K. N.", 
        "id": "sg:person.016067215057.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016067215057.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.21925.3d", 
          "name": [
            "Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gannon", 
        "givenName": "Jessica M.", 
        "id": "sg:person.01064227240.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064227240.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Icahn School of Medicine at Mount Sinai (Bronx) Program, James J. Peters VA Medical Center, Bronx, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.274295.f", 
          "name": [
            "Icahn School of Medicine at Mount Sinai (Bronx) Program, James J. Peters VA Medical Center, Bronx, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Acharya", 
        "givenName": "Luna", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pittsburgh Medical Center \u2013 Northwest, Seneca, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.412689.0", 
          "name": [
            "University of Pittsburgh Medical Center \u2013 Northwest, Seneca, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rai", 
        "givenName": "Abhishek", 
        "id": "sg:person.014546230357.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014546230357.32"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2017-09-12", 
    "datePublishedReg": "2017-09-12", 
    "description": "Bipolar Disorder is a mood disorder that can be quite severe for subgroups of patients, and often such patients manifest deficits in attention, concentration, memory, and executive functions that persist even when they are relatively well. Cognitive concerns can impair daily life functioning and impact employment, education, and interpersonal relationships. Main line treatments for bipolar disorder typically do not address cognitive impairments, and some treatments may actually worsen cognitive deficits. Treatment development for cognitive impairments in bipolar disorder is truly in its infancy; extracts of Ashwagandha (Withania somnifera) may hold promise as a potential treatment option. The bioactive constituents of Ashwagandha, including withanolides, indosides, Withaferin A, and others, possess anti-inflammatory-immunomodulatory, anti-oxidant, cortisol lowering, anti-stress, pro-cholinergic, anti-glutamatergic and neuroprotective properties, the very processes that are thought to underlie cognitive impairments not only in in bipolar disorder but also in other psychiatric disorders like schizophrenia and major depression. This chapter reviews this in detail and highlights the preliminary randomized controlled study assessing an extract of Ashwagandha for improving cognition in bipolar disorder. The chapter also explores the potential role of Ashwagandha extracts in the treatment of other neurocognitive disorders, and it concludes by summarizing additional future research needed to realize the potential of this ancient medicinal plant for the treatment of human ailments.", 
    "editor": [
      {
        "familyName": "Kaul", 
        "givenName": "Sunil C.", 
        "type": "Person"
      }, 
      {
        "familyName": "Wadhwa", 
        "givenName": "Renu", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-319-59192-6_17", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-319-59191-9", 
        "978-3-319-59192-6"
      ], 
      "name": "Science of Ashwagandha: Preventive and Therapeutic Potentials", 
      "type": "Book"
    }, 
    "keywords": [
      "cognitive impairment", 
      "bipolar disorder", 
      "neurocognitive disorders", 
      "cognitive concerns", 
      "executive function", 
      "cognitive deficits", 
      "additional future research", 
      "interpersonal relationships", 
      "treatment development", 
      "cognitive dysfunction", 
      "future research", 
      "mood disorders", 
      "psychiatric disorders", 
      "impairment", 
      "subgroup of patients", 
      "potential treatment option", 
      "daily life", 
      "deficits", 
      "disorders", 
      "major depression", 
      "such patients", 
      "line treatment", 
      "neuroprotective properties", 
      "treatment options", 
      "cognition", 
      "very process", 
      "Ashwagandha extract", 
      "memory", 
      "ancient medicinal plant", 
      "Withaferin A", 
      "potential role", 
      "patients", 
      "treatment", 
      "schizophrenia", 
      "Ashwagandha", 
      "bioactive constituents", 
      "potential utility", 
      "depression", 
      "human ailments", 
      "infancy", 
      "persons", 
      "attention", 
      "medicinal plants", 
      "research", 
      "dysfunction", 
      "relationship", 
      "extract", 
      "chapter", 
      "subgroups", 
      "life", 
      "education", 
      "ailments", 
      "options", 
      "concern", 
      "bipolar", 
      "role", 
      "utility", 
      "employment", 
      "study", 
      "promise", 
      "process", 
      "development", 
      "withanolides", 
      "lowering", 
      "concentration", 
      "function", 
      "potential", 
      "constituents", 
      "detail", 
      "properties", 
      "plants"
    ], 
    "name": "The Potential Utility of Ashwagandha for Improving Cognitive Dysfunction in Persons with Bipolar or Other Neurocognitive Disorders", 
    "pagination": "345-371", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1091686017"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-319-59192-6_17"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-319-59192-6_17", 
      "https://app.dimensions.ai/details/publication/pub.1091686017"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-11-24T21:16", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/chapter/chapter_318.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-319-59192-6_17"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-59192-6_17'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-59192-6_17'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-59192-6_17'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-59192-6_17'


 

This table displays all metadata directly associated to this object as RDF triples.

173 TRIPLES      22 PREDICATES      97 URIs      87 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-319-59192-6_17 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 anzsrc-for:1109
4 anzsrc-for:17
5 anzsrc-for:1701
6 schema:author N6c45b3f95de94c658eaa8c1a30407415
7 schema:datePublished 2017-09-12
8 schema:datePublishedReg 2017-09-12
9 schema:description Bipolar Disorder is a mood disorder that can be quite severe for subgroups of patients, and often such patients manifest deficits in attention, concentration, memory, and executive functions that persist even when they are relatively well. Cognitive concerns can impair daily life functioning and impact employment, education, and interpersonal relationships. Main line treatments for bipolar disorder typically do not address cognitive impairments, and some treatments may actually worsen cognitive deficits. Treatment development for cognitive impairments in bipolar disorder is truly in its infancy; extracts of Ashwagandha (Withania somnifera) may hold promise as a potential treatment option. The bioactive constituents of Ashwagandha, including withanolides, indosides, Withaferin A, and others, possess anti-inflammatory-immunomodulatory, anti-oxidant, cortisol lowering, anti-stress, pro-cholinergic, anti-glutamatergic and neuroprotective properties, the very processes that are thought to underlie cognitive impairments not only in in bipolar disorder but also in other psychiatric disorders like schizophrenia and major depression. This chapter reviews this in detail and highlights the preliminary randomized controlled study assessing an extract of Ashwagandha for improving cognition in bipolar disorder. The chapter also explores the potential role of Ashwagandha extracts in the treatment of other neurocognitive disorders, and it concludes by summarizing additional future research needed to realize the potential of this ancient medicinal plant for the treatment of human ailments.
10 schema:editor Ndfc250bf92aa41f18c28264576b5c9ec
11 schema:genre chapter
12 schema:isAccessibleForFree false
13 schema:isPartOf N5451967e1ca8419587c4eccd425b6b79
14 schema:keywords Ashwagandha
15 Ashwagandha extract
16 Withaferin A
17 additional future research
18 ailments
19 ancient medicinal plant
20 attention
21 bioactive constituents
22 bipolar
23 bipolar disorder
24 chapter
25 cognition
26 cognitive concerns
27 cognitive deficits
28 cognitive dysfunction
29 cognitive impairment
30 concentration
31 concern
32 constituents
33 daily life
34 deficits
35 depression
36 detail
37 development
38 disorders
39 dysfunction
40 education
41 employment
42 executive function
43 extract
44 function
45 future research
46 human ailments
47 impairment
48 infancy
49 interpersonal relationships
50 life
51 line treatment
52 lowering
53 major depression
54 medicinal plants
55 memory
56 mood disorders
57 neurocognitive disorders
58 neuroprotective properties
59 options
60 patients
61 persons
62 plants
63 potential
64 potential role
65 potential treatment option
66 potential utility
67 process
68 promise
69 properties
70 psychiatric disorders
71 relationship
72 research
73 role
74 schizophrenia
75 study
76 subgroup of patients
77 subgroups
78 such patients
79 treatment
80 treatment development
81 treatment options
82 utility
83 very process
84 withanolides
85 schema:name The Potential Utility of Ashwagandha for Improving Cognitive Dysfunction in Persons with Bipolar or Other Neurocognitive Disorders
86 schema:pagination 345-371
87 schema:productId N1ffa7b6c5ac4434aab30195ea67ff487
88 N5f9c7a0e21cd4b9b886cd59046d99184
89 schema:publisher Nd43bcefc3dba4c35a19c2965fe9d2e1c
90 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091686017
91 https://doi.org/10.1007/978-3-319-59192-6_17
92 schema:sdDatePublished 2022-11-24T21:16
93 schema:sdLicense https://scigraph.springernature.com/explorer/license/
94 schema:sdPublisher Nab1510ea626e4a51832701db15165c08
95 schema:url https://doi.org/10.1007/978-3-319-59192-6_17
96 sgo:license sg:explorer/license/
97 sgo:sdDataset chapters
98 rdf:type schema:Chapter
99 N0b728fd8545b46779c133cfb6a70ae12 rdf:first sg:person.014546230357.32
100 rdf:rest rdf:nil
101 N1ffa7b6c5ac4434aab30195ea67ff487 schema:name dimensions_id
102 schema:value pub.1091686017
103 rdf:type schema:PropertyValue
104 N4aee296fb64f448aa065b3814a2eb02a rdf:first Na10a0b8f8ee847b689a04b464e47cb55
105 rdf:rest rdf:nil
106 N51488389cf1e46d7954cd377bf82103f schema:familyName Kaul
107 schema:givenName Sunil C.
108 rdf:type schema:Person
109 N5451967e1ca8419587c4eccd425b6b79 schema:isbn 978-3-319-59191-9
110 978-3-319-59192-6
111 schema:name Science of Ashwagandha: Preventive and Therapeutic Potentials
112 rdf:type schema:Book
113 N5f9c7a0e21cd4b9b886cd59046d99184 schema:name doi
114 schema:value 10.1007/978-3-319-59192-6_17
115 rdf:type schema:PropertyValue
116 N6c45b3f95de94c658eaa8c1a30407415 rdf:first sg:person.016067215057.20
117 rdf:rest N769f51b3acf2472ca76d15db2fa4987e
118 N769f51b3acf2472ca76d15db2fa4987e rdf:first sg:person.01064227240.73
119 rdf:rest N9a89c44415ae4e18a1b0951d42dc05ac
120 N9a89c44415ae4e18a1b0951d42dc05ac rdf:first Na15af4e0a13d4e17b2b091cd31cd81f1
121 rdf:rest N0b728fd8545b46779c133cfb6a70ae12
122 Na10a0b8f8ee847b689a04b464e47cb55 schema:familyName Wadhwa
123 schema:givenName Renu
124 rdf:type schema:Person
125 Na15af4e0a13d4e17b2b091cd31cd81f1 schema:affiliation grid-institutes:grid.274295.f
126 schema:familyName Acharya
127 schema:givenName Luna
128 rdf:type schema:Person
129 Nab1510ea626e4a51832701db15165c08 schema:name Springer Nature - SN SciGraph project
130 rdf:type schema:Organization
131 Nd43bcefc3dba4c35a19c2965fe9d2e1c schema:name Springer Nature
132 rdf:type schema:Organisation
133 Ndfc250bf92aa41f18c28264576b5c9ec rdf:first N51488389cf1e46d7954cd377bf82103f
134 rdf:rest N4aee296fb64f448aa065b3814a2eb02a
135 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
136 schema:name Medical and Health Sciences
137 rdf:type schema:DefinedTerm
138 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
139 schema:name Clinical Sciences
140 rdf:type schema:DefinedTerm
141 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
142 schema:name Neurosciences
143 rdf:type schema:DefinedTerm
144 anzsrc-for:17 schema:inDefinedTermSet anzsrc-for:
145 schema:name Psychology and Cognitive Sciences
146 rdf:type schema:DefinedTerm
147 anzsrc-for:1701 schema:inDefinedTermSet anzsrc-for:
148 schema:name Psychology
149 rdf:type schema:DefinedTerm
150 sg:person.01064227240.73 schema:affiliation grid-institutes:grid.21925.3d
151 schema:familyName Gannon
152 schema:givenName Jessica M.
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064227240.73
154 rdf:type schema:Person
155 sg:person.014546230357.32 schema:affiliation grid-institutes:grid.412689.0
156 schema:familyName Rai
157 schema:givenName Abhishek
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014546230357.32
159 rdf:type schema:Person
160 sg:person.016067215057.20 schema:affiliation grid-institutes:grid.21925.3d
161 schema:familyName Roy Chengappa
162 schema:givenName K. N.
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016067215057.20
164 rdf:type schema:Person
165 grid-institutes:grid.21925.3d schema:alternateName Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
166 schema:name Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
167 rdf:type schema:Organization
168 grid-institutes:grid.274295.f schema:alternateName Icahn School of Medicine at Mount Sinai (Bronx) Program, James J. Peters VA Medical Center, Bronx, NY, USA
169 schema:name Icahn School of Medicine at Mount Sinai (Bronx) Program, James J. Peters VA Medical Center, Bronx, NY, USA
170 rdf:type schema:Organization
171 grid-institutes:grid.412689.0 schema:alternateName University of Pittsburgh Medical Center – Northwest, Seneca, PA, USA
172 schema:name University of Pittsburgh Medical Center – Northwest, Seneca, PA, USA
173 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...